Walgreens Boots Alliance (NASDAQ:WBA) Releases FY 2024 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 2.800-2.950 for the period, compared to the consensus earnings per share estimate of 3.200. The company issued revenue guidance of -. Walgreens Boots Alliance also updated its FY24 guidance to $2.80-$2.95 EPS.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. UBS Group decreased their target price on Walgreens Boots Alliance from $22.00 to $17.00 and set a neutral rating for the company in a research note on Monday. Evercore ISI decreased their target price on Walgreens Boots Alliance from $18.00 to $17.00 and set an in-line rating for the company in a research note on Monday, June 3rd. SVB Leerink decreased their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a market perform rating for the company in a research note on Monday, March 18th. TD Cowen decreased their target price on Walgreens Boots Alliance from $37.00 to $35.00 and set a buy rating for the company in a research note on Wednesday, April 3rd. Finally, Morgan Stanley decreased their target price on Walgreens Boots Alliance from $16.00 to $13.00 and set an underweight rating for the company in a research note on Friday, May 31st. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of Hold and an average price target of $23.07.

Walgreens Boots Alliance Trading Down 1.2 %

NASDAQ WBA opened at $12.04 on Friday. Walgreens Boots Alliance has a twelve month low of $11.68 and a twelve month high of $31.32. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. The stock has a market cap of $10.39 billion, a price-to-earnings ratio of -1.74, a PEG ratio of 0.98 and a beta of 0.78. The firm’s 50 day moving average price is $16.72 and its two-hundred day moving average price is $20.33.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing the consensus estimate of $0.67 by ($0.04). Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The company had revenue of $36.40 billion for the quarter, compared to analysts’ expectations of $35.94 billion. During the same quarter in the prior year, the firm earned $1.00 earnings per share. The company’s revenue was up 2.8% on a year-over-year basis. Equities analysts anticipate that Walgreens Boots Alliance will post 3.21 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.31%. The ex-dividend date was Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -14.29%.

Insiders Place Their Bets

In related news, CFO Manmohan Mahajan bought 6,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Tuesday, April 2nd. The stock was acquired at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the purchase, the chief financial officer now owns 166,969 shares in the company, valued at $3,235,859.22. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Inderpal S. Bhandari bought 3,000 shares of the business’s stock in a transaction dated Thursday, April 11th. The stock was bought at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the purchase, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Manmohan Mahajan bought 6,000 shares of the business’s stock in a transaction dated Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the purchase, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. Company insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.